Stock comparison
GILEAD SCIENCES, INC. is 15.0x more valuable than BIO-TECHNE Corp by market capitalization ($167.49 B vs $11.14 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
GILD is larger
GILEAD SCIENCES, INC. is 15.0x more valuable than BIO-TECHNE Corp by market capitalization ($167.49 B vs $11.14 B).
Market value leader
GILD
GILEAD SCIENCES, INC. is 15.0x more valuable than BIO-TECHNE Corp by market capitalization ($167.49 B vs $11.14 B).
Revenue leader
GILD
TECH: $1.22B vs GILD: $29.44B.
Profit leader
GILD
TECH: $73.40M vs GILD: $8.51B.
Margin leader
GILD
TECH: 6.0% vs GILD: 28.9% net margin.
| Metric | TECH | GILD |
|---|---|---|
| Market cap | $11.14 B | $167.49 B |
| US-listed rank | #893 | #92 |
| Revenue (latest FY) | $1.22B | $29.44B |
| Net income (latest FY) | $73.40M | $8.51B |
| Net margin | 6.0% | 28.9% |
| P/E (trailing FY) | 151.8x | 19.7x |
| SEC filings | 1,229 | 968 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
GILEAD SCIENCES, INC. is 15.0x more valuable than BIO-TECHNE Corp by market capitalization ($167.49 B vs $11.14 B).
In their latest fiscal years, BIO-TECHNE Corp reported $1.22B in revenue while GILEAD SCIENCES, INC. reported $29.44B.
Full pages: BIO-TECHNE Corp and GILEAD SCIENCES, INC., or browse the full rankings.